These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15136479)

  • 41. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin.
    Kanno T; Siebenlist U
    J Immunol; 1996 Dec; 157(12):5277-83. PubMed ID: 8955173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.
    An J; Rettig MB
    Mol Cell Biol; 2005 Sep; 25(17):7546-56. PubMed ID: 16107702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
    Shigeoka Y; Igishi T; Matsumoto S; Nakanishi H; Kodani M; Yasuda K; Hitsuda Y; Shimizu E
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):146-52. PubMed ID: 14691717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis.
    Yang YM; Conaway CC; Chiao JW; Wang CX; Amin S; Whysner J; Dai W; Reinhardt J; Chung FL
    Cancer Res; 2002 Jan; 62(1):2-7. PubMed ID: 11782348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blocking of PI3K/Akt pathway enhances apoptosis induced by SN-38, an active form of CPT-11, in human hepatoma cells.
    Koizumi N; Hatano E; Nitta T; Tada M; Harada N; Taura K; Ikai I; Shimahara Y
    Int J Oncol; 2005 May; 26(5):1301-6. PubMed ID: 15809721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition.
    Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR
    Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.
    Rong R; He Q; Liu Y; Sheikh MS; Huang Y
    Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Akt is more than just a Bad kinase.
    Khwaja A
    Nature; 1999 Sep; 401(6748):33-4. PubMed ID: 10485701
    [No Abstract]   [Full Text] [Related]  

  • 51. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
    Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
    Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo.
    West KA; Linnoila IR; Brognard J; Belinsky S; Harris C; Dennis PA
    Chest; 2004 May; 125(5 Suppl):101S-2S. PubMed ID: 15136436
    [No Abstract]   [Full Text] [Related]  

  • 55. Cancer: A tumour gene's fatal flaws.
    Downward J
    Nature; 2009 Nov; 462(7269):44-5. PubMed ID: 19890318
    [No Abstract]   [Full Text] [Related]  

  • 56. Receptor upregulation enhances cell surface receptor targeted therapies.
    Frankel AE
    Leuk Res; 2002 Dec; 26(12):1069-71. PubMed ID: 12443877
    [No Abstract]   [Full Text] [Related]  

  • 57. Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.
    Franks SE; Briah R; Jones RA; Moorehead RA
    Oncotarget; 2016 Jan; 7(3):3297-316. PubMed ID: 26654940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of the Akt/nuclear factor-kappaB signaling axis in developing lung neoplasia.
    Tichelaar JW; Zhang Y; LeRiche JC; Lam S; Anderson MW
    Chest; 2004 May; 125(5 Suppl):153S. PubMed ID: 15136479
    [No Abstract]   [Full Text] [Related]  

  • 59. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.
    Ozes ON; Mayo LD; Gustin JA; Pfeffer SR; Pfeffer LM; Donner DB
    Nature; 1999 Sep; 401(6748):82-5. PubMed ID: 10485710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.